Author:
Weiß Michael,Wintergerst Uwe,Müller Andreas
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. American Academy of Pediatrics (ed) (2012) Red Book: report of the Committee on Infectious Diseases, 29th edn. American Academy of Pediatrics, Elk Grove Village
2. Cohen-Wolkowiez M, Benjamin DK Jr, Piper L et al. (2011) Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates. Clin Pharmacol Ther 89: 702–707
3. Cornely OA, Maertens J, Winston DJ et al. (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356: 409–411
4. Gallin JI, Alling DW, Malech HL et al. (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348: 2416–2422
5. Merlin E, Galambrun C, Ribaud P et al. (2006) Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infect Dis J 12: 1186–1188